SOROS FUND MANAGEMENT LLC 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 08:54 am Sale |
2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
SOROS FUND MANAGEMENT LLC | 0 0.000% |
-2,487,581 (Position Closed) |
Filing |
| 2020-07-10 4:09 pm Purchase |
2020-06-30 | 13G | Xeris Biopharma Holdings, Inc. XERS |
SOROS FUND MANAGEMENT LLC | 2,487,581 5.260% |
2,487,581 (New Position) |
Filing |